Advertisement

Topics

Latest "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" News Stories

02:21 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" found in our extensive news archives from over 250 global news sources.

More Information about ORYZON present preclinical data 2001 Neuroscience 2017 meeting on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ORYZON present preclinical data 2001 Neuroscience 2017 meeting for you to read. Along with our medical data and news we also list ORYZON present preclinical data 2001 Neuroscience 2017 meeting Clinical Trials, which are updated daily. BioPortfolio also has a large database of ORYZON present preclinical data 2001 Neuroscience 2017 meeting Companies for you to search.

Showing "ORYZON present preclinical data 2001 Neuroscience 2017 meeting" News Articles 1–25 of 31,000+

Tuesday 26th March 2019

Optimizing biological inferences from single-cell data


Identification of optimal prediction models using multi-omic data for selecting hybrid rice

Monday 25th March 2019

Silver Bonding Wires Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Silver Bonding Wires report provides an independent information about the Silver Bonding Wires industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development...


MEDIKEY, Blockchain to Reward Participants for Sharing Health Information and Becoming Healthy, Launches Main Net

MEDIKEY, a blockchain-based platform to reward participants if they share health information and become healthy, launched the main net on Oct. 1, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005015/en/

Investigators at @UTSWNews release new data identifying two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection: http://ow.ly/OdHm30oba7d 

Investigators at @UTSWNews release new data identifying two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection: http://ow.ly/OdHm30oba7d 

Duke University to Pay $112.5 Million to Settle Claims of Research Misconduct

The university submitted falsified data in connection with 30 grants obtained from the N.I.H. and E.P.A., according to a whistle-blower lawsuit.

Women at Breast Implant Hearing Call for Disclosure of Safety Risks

While industry representatives insisted the implants are safe, others at an F.D.A. panel meeting urged for warnings about links to illnesses and cancer.

Rotary Club’s ‘3H Medical Outreach Program’ receives RM50,000 sponsorship from Fusionex

Fusionex contributed RM50,000 to the 3H Health Awareness Campaign organized by the Rotary Club of Kuala Lumpur (RCKL) DiRaja. The program aims to create awareness regarding the ‘3Hs’ or ‘three highs’, namely high blood pressure, high cholesterol and high blood sugar. This press release features multimedia. View the full release here: https://www.businessw...

. @DukeU scientists report that endocrine-disrupting chemicals present in household dust promote the development of fat cells in a cell model: http://ow.ly/dxkx30obaYd 

. @DukeU scientists report that endocrine-disrupting chemicals present in household dust promote the development of fat cells in a cell model: http://ow.ly/dxkx30obaYd 

bluebird bio Statement on European Regulatory Status of LentiGlobin™

A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as p...

Oncology Sponsors Getting A Jump On Pediatric Study Requirements, US FDA Says

Beginning in August 2020, applications for some novel cancer drugs and biologics will have to include reports on molecularly targeted...   

Working Out Helps Boost Memory for the Long-term, New Study Finds

Whether it’s playing basketball, lifting weights or taking a brisk walk, a good workout can leave you feeling energized and confident. It’s well known that frequent bouts of exercise make you stronger and improve your cardiovascular health, but a new study is adding another, unexpected benefit to the mix. Research presented at the annual Cognitive Neuroscience Society meeting on March 24 show...

'Blindsided': Women speak about breast implant illnesses at FDA hearing

New concerns about possible long-term health problems a focus at the two-day meeting.

Chemicals in Household Dust May Promote Fat Cell Development

NewsEndocrine-disrupting chemicals present in household dust could contribute to increased growth in children relative to their age.Cont

Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer

Findings Presented at ENDO 2019 Conference Veracyte, Inc. (Nasdaq: VCYT) announced today that new data from the Afirma® Xpression Atlas suggest that the majority of newly diagnosed medullary thyroid cancers (MTC) are associated with variants from three genes. The findings shed new light on the genomic underpinning of this rare, but aggressive, ...

Superior Dental Care Provides Notice of Data Security Incident

Superior Dental Care (SDC), a dental insurance carrier, today announced that a recent data security incident may have resulted in unauthorized access to some of its members’ personal information. SDC first identified suspicious activity within an employee’s email account on Jan. 23, 2019. Steps were taken immediately to secure the email accoun...

Research Suggests New Drug Targets for Osteoporosis

NewsScientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis.

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia

- The European Medicines Agency Human Medicines Committee (CHMP) has approved a Conditional Marketing Authorisation in the European Union for Zynteglo™ Associaz

Physicians’ Education Resource® Presents “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know”

This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting Physicians’ Education Resource® (PER®), a worldwide leader in continuing medical education (CME), will conduct a live CME-accredited activity, “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know,” as a satelli...

ENDO: Diabetes Underestimated With HbA1c Criteria

MONDAY, March 25, 2019 -- The prevalence of diabetes mellitus (DM) is underestimated and normal glucose tolerance (NGT) is overestimated using hemoglobin A1c (A1c) criteria, according to a study presented at the annual meeting of The Endocrine...

Proteostasis Puts Best Face On Unspectacular CF Combo Data

With data showing a lung function and sweat chloride benefit for its proprietary CFTR-modulating triplet, Proteostasis says it’s moving ahead...   

Analysts: Proteostasis Data Are No Boost vs. Vertex in Cystic Fibrosis

As with cancer and HIV infections, progress in treatment for the genetic disorder cystic fibrosis has come with ever-more sophisticated cocktails of drugs. Proteostasis Therapeutics (NASDAQ: PTI) is one of the firms trying to catch up to cystic fibrosis leader Vertex Pharmaceuticals (NASDAQ: VRTX), but data it reported this morning did not satisfy investors, who […]

Teva launches generic Exjade

DATA: Global Device Approvals Snapshot: March 18 – March 25, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week FDA...   

Onxeo to Present Data supporting Lead Asset AsiDNA in 5 Poster Presentations at 2019 American Association for Cancer Research Annual Meeting

Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), ("Onxeo" or "the Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs targe...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks